Quarterly Report I 20/21
September 2020 – November 2020, Diamyd Medical AB (publ), Fiscal year 2020/2021Figures in parentheses relate to the corresponding period previous financial year. September 1, 2020 – November 30, 2020 · Net result: MSEK 104.9 (-6.8). The increase compared to previous year is a one-off effect of corresponding MSEK 117.5 due to profit from divestment of shares in Companion Medical, Inc. · Result per share: SEK 1.5 (-0.1) · Cash flow from operating activities: MSEK -14.1 (-6.1) · Cash and cash equivalents at November 30, 2020: MSEK 173.0 (50.6) Significant events first